BV-2 cells were exposed to 100 ng/mL lipopolysaccharide (LPS; Sigma-Aldrich) and interferon (IFN)-γ (20 ng/mL; Peprotech) for 24 h. Subsequently, BV2 cells were transfected with TSPO siRNA and siRNA-NC (100 nM; Genechem) for 6 h using Lipofectamine 2000 (Invitrogen) according to the manufacturer’s instructions and harvested 12 h after transfection. Cells were divided into two groups: LPS+IFN-γ+ si-NC and LPS+IFN-γ+ si-TSPO groups. The cells were then treated with PK11195 (0.5 Μm; Sigma-Aldrich) for 6 h (LPS+IFN-γ+ PK11195 and LPS+IFN-γ+ si-TSPO+PK11195 groups, respectively).
Pk11195
PK11195 is a chemical compound used in laboratory research. It functions as a selective ligand for the translocator protein (TSPO), which is involved in various cellular processes. The core function of PK11195 is to serve as a research tool for the study of TSPO and its associated biological mechanisms.
Lab products found in correlation
38 protocols using pk11195
TSPO Modulation in Activated Microglia
BV-2 cells were exposed to 100 ng/mL lipopolysaccharide (LPS; Sigma-Aldrich) and interferon (IFN)-γ (20 ng/mL; Peprotech) for 24 h. Subsequently, BV2 cells were transfected with TSPO siRNA and siRNA-NC (100 nM; Genechem) for 6 h using Lipofectamine 2000 (Invitrogen) according to the manufacturer’s instructions and harvested 12 h after transfection. Cells were divided into two groups: LPS+IFN-γ+ si-NC and LPS+IFN-γ+ si-TSPO groups. The cells were then treated with PK11195 (0.5 Μm; Sigma-Aldrich) for 6 h (LPS+IFN-γ+ PK11195 and LPS+IFN-γ+ si-TSPO+PK11195 groups, respectively).
Detailed TSPO Ligand Characterization
Zebrafish Embryo 4-HNE Intervention
Synthesis of TSPO Ligands for Pharmaceutical Research
Pharmacological Interventions for Diabetes and Depression
Cell Line Authentication and Maintenance
Radiolabeling and Quantification of TSPO in Cardiac Tissue
Benzodiazepine and TSPO Ligand Effects
In Vitro Autoradiography of TSPO
Ligand Screening for Nuclear Receptors
rifampicin (rif), TCPOBOP, and PK11195 were obtained from Sigma-Aldrich
(St. Louis, Missouri, United States, now Merck), which is now known
as Merck (Darmstadt, Germany). Phenobarbital (Luminal 200 mg/mL injection)
was manufactured by Desitin Pharma spol. s.r.o. (Prague, Czech Republic).
Ligands for nuclear receptors (GW3965, thyroxin, obeticholic acid,
dexamethasone, fenofibrate, GW501516, rosiglitazone, 3-methylcholanthrene,
calcitriol, testosterone, and estradiol) were purchased from Sigma-Aldrich
(now Merck). The prototype ligands were used at 100 nM (dexamethasone,
calcitriol), 1 μM (thyroxin), or 10 μM concentrations.
The compounds were dissolved in DMSO, and the final concentration
of DMSO in the entire reaction mixture or cultivation media was 0.1%.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!